Article Details
Retrieved on: 2025-03-17 21:00:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Xeris Biopharma said Gvoke VialDx is contraindicated in patients with pheochromocytoma, insulinoma, glucagonoma and prior sensitivity reaction to ...
Article found on: www.diagnosticimaging.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here